AHR and COVID-19: Additionally, lipopolysaccharide (LPS)-induced inflammation serves as a secondary trigger for AHR activation, compounding the severity of COVID-19 (Chen Q. et al., 2023; Ramasamy and Subbian, 2021; Sen, 2022).